📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Development of a cost-effective ovine antibody-based therapy against SARS-CoV-2 infection and contribution of antibodies specific to the spike subunit proteins. (2022)

First Author: Findlay-Wilson S

Attributed to: Development of an ovine polyclonal immunoglobulin therapy against COVID-19. funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.antiviral.2022.105332

PubMed Identifier: 35533779

Publication URI: http://europepmc.org/abstract/MED/35533779

Type: Journal Article/Review

Volume: 203

Parent Publication: Antiviral research

ISSN: 0166-3542